[go: up one dir, main page]

CN115784918B - Preparation method of high-purity ubenimex intermediate - Google Patents

Preparation method of high-purity ubenimex intermediate Download PDF

Info

Publication number
CN115784918B
CN115784918B CN202211484290.2A CN202211484290A CN115784918B CN 115784918 B CN115784918 B CN 115784918B CN 202211484290 A CN202211484290 A CN 202211484290A CN 115784918 B CN115784918 B CN 115784918B
Authority
CN
China
Prior art keywords
compound
acid
hydroxy
aqueous solvent
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211484290.2A
Other languages
Chinese (zh)
Other versions
CN115784918A (en
Inventor
范有平
卢铁刚
胡同军
朱华
邵波
王颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Qingmu Pharmaceutical Co ltd
Original Assignee
Sichuan Qingmu Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Qingmu Pharmaceutical Co ltd filed Critical Sichuan Qingmu Pharmaceutical Co ltd
Priority to CN202211484290.2A priority Critical patent/CN115784918B/en
Publication of CN115784918A publication Critical patent/CN115784918A/en
Application granted granted Critical
Publication of CN115784918B publication Critical patent/CN115784918B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a method for preparing high-purity intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid of Wufenmei Si. Compound a is first separated to obtain compound 1a, then hydrogenated and reduced to obtain compound 1b, and finally hydrolyzed to obtain high-purity intermediate c. Using the reaction route of the present invention, the separation yield is increased, the overall yield of intermediate c is increased, the purity is also high, the material usage is reduced, the production cost is lower, and it is more economical and environmentally friendly.

Description

Preparation method of high-purity ubenimex intermediate
Technical Field
The invention relates to the field of organic chemistry, in particular to a preparation method of a high-purity ubenimex intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid.
Background
Ubenimex (Ubenimex), its chemical name is: n- [ (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyryl ] -L-leucine; the molecular formula: c 16H24N2O4; molecular weight: 308.37; the structural formula is as follows:
Ubenimex is a peptide antitumor drug, which is a dipeptide compound isolated from culture solution of Streptomyces olivaceus by Japanese scholares Mei Zebin in 1976, and can competitively inhibit aminopeptidase B, leucine peptidase, caspase and the like, induce apoptosis of tumor cells and promote host immune function. Can be used in combination with chemotherapy, radiotherapy and other solid tumor patients after leukemia, multiple myeloma, myelodysplastic syndrome and hematopoietic stem cell transplantation.
The ubenimex has a complex structure, contains 3 chiral centers and theoretically has 7 stereoisomers, so that how to ensure that 3 chiral centers are correctly formed and the optical purity meets the quality requirement is the primary task of synthesizing ubenimex.
(2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (compound c) is an important intermediate for the preparation of ubenimex. The route for the preparation of (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (compound c) is as follows, in view of the reported preparation methods for Wu Benmei s:
The compound a is firstly hydrogenated and reduced, then the compound b is subjected to resolution reaction to obtain salt, then acidolysis is carried out to obtain the compound 1b, and deacetylation is carried out to obtain the intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (compound c) of ubenimex.
Journal of Antibiotics,1983, 36 (6): 695-699 reports a practical ubenimex process, which comprises taking acetophenone as raw material, and carrying out bromination, amination, acetylation, aldol condensation, hydrogenation reduction, resolution, deacetylation, amino protection, amide condensation and deprotection reaction to obtain ubenimex. The method also comprises the steps of firstly hydrogenating the compound a to obtain a compound b, then carrying out chiral resolution on the compound b, and carrying out acidolysis and hydrolysis to obtain the ubenimex intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (compound c). Wherein this route for compound a to compound c was calculated to yield about 22.32%.
Patent CN101891647 a discloses a method for resolving compound b by using L-lysine, L-arginine and L-histidine, to obtain ubenimex intermediate (2 s,3 r) -3-acetamido-2-hydroxy-4-phenylbutyric acid, which requires multiple recrystallization operations, and preferably adds seed crystals to separate out crystals in the salting-out process, and has complex operation, and the yield of resolved compound b is only about 33.2%, which is not beneficial to industrial production.
Patent CN107098827 a discloses a method for resolving compound b by using S-1-naphthylethylamine, S-1- (2-naphthyl), L-phenylglycinol and L-amphetamine as resolving agents, to obtain ubenimex intermediate (2S, 3 r) -3-acetamido-2-hydroxy-4-phenylbutyric acid, the resolving yield of the method is about 35-37%, and the resolving yield is not high.
The above patents all refer to chiral resolution of the compound b, wherein the compound b is positioned in the intermediate of the sixth step of the ubenimex process chain, and the resolution yield is about 30%, which means that more than 60% of materials and solvents before the intermediate b are ineffective. The route from the compound a to the compound c has the total yield of about 22 percent, low cost, high emission in the production process, low optical purity and no contribution to industrial production. For industrial production, the continuous pursuit of enterprises to reduce cost and reduce environmental pollution caused by waste emission is realized by improving yield and reducing raw material consumption to obtain high-quality products.
Disclosure of Invention
The invention aims to improve the defects of the prior art, and the threo-2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound a) obtained from the fourth step of reaction is split, and is directly hydrolyzed after hydrogenation reduction to obtain (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid. The method has the advantages of early resolution, less material use, improved resolution yield, high intermediate purity and simpler operation.
The invention provides a preparation method of a high-purity ubenimex intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (c), which is characterized in that the reaction equation is as follows:
Separating the compound a by a resolution reagent to obtain a compound 1a, then hydrogenating the compound 1a to obtain a compound 1b, and hydrolyzing the compound to obtain an intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (c); wherein the resolving agent is selected from N-N-octyl-D-glucosamine, S-alpha-phenylethylamine, L-lysine or L-arginine.
In some embodiments, the resolving agent is preferably N-octyl-D-glucosamine.
In some embodiments, the compound a, threo-2-hydroxy-3-acetamido-4-phenylcarbonylbutyric acid, consists of compound 1a and compound 2 a:
in some embodiments, the molar ratio of compound a to resolving agent is 1: (0.5 to 7), preferably 1: (0.8 to 5), more preferably 1: (1-5).
In some embodiments, the process for preparing intermediate c comprises the steps of:
1) Mixing the compound a with a resolution reagent in an aqueous solvent to form salt, cooling, crystallizing and separating out the salt, and separating to obtain salt of the compound 1a and the resolution reagent; wherein the temperature range at which the compound a and the resolving agent are mixed in the aqueous solvent is 0 to 100 ℃, for example, 50 to 100 ℃,20 to 80 ℃ and the like; the temperature reduction range of the mixture is-20-50 ℃, preferably 0-40 ℃;
2) Dissolving the salt obtained in the step 1) in an aqueous solution, adding a proper amount of acid to enable the compound 1a to be free and separated out, and separating to obtain (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a) with high purity:
3) Adding the compound obtained in the step 2) into a solvent for hydrogenation to obtain chiral (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid (compound 1 b):
4) Hydrolyzing the compound 1b obtained in the step 3) in acid to obtain a chiral compound (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (compound c):
In some embodiments, the aqueous solvent described in step 1) is selected from one of isopropanol, ethanol, acetone, sec-butanol; the water content of the solvent is in the range of 0.5% to 15%, preferably 1% to 10%, and more preferably 3% to 5%.
In some embodiments, the weight ratio of compound a to the aqueous solvent in step 1) is from 1 (0.5 to 120), preferably from 1 (1 to 100), and more preferably from 1 (4 to 50).
In some embodiments, the acid described in step 2) or 4) is a protic acid, such as hydrochloric acid, nitric acid, sulfuric acid, trifluoroacetic acid, acetic acid, benzoic acid, sulfonic acid, phosphoric acid, and the like.
The preparation process of the invention has the following advantages:
1. compared with the prior art, the method has the advantages that the resolution of the compound b after resolution reduction is generally different, and the method advances the resolution, uses fewer materials, reduces the production cost, improves the yield of the intermediate c by ten percent, and greatly improves the purity of the product.
2. According to the invention, the resolution reagent N-N-octyl-D-glucosamine, S-alpha-phenethylamine, L-lysine or L-arginine is selected for resolution of the compound a, and compared with other resolution reagents, the resolution yield is higher, and the resolution yield is higher than 40%, especially the resolution yield of N-N-octyl-D-glucosamine is higher than 42.5%.
3. The method has the advantages of simpler operation, less resolution times, good resolution effect, better purity of the prepared intermediate c and suitability for industrial production.
Drawings
FIG. 1 is an optical purity HPLC chart of Compound 1a prepared in example 1
FIG. 2 is an optical purity HPLC chart of Compound 1a prepared in example 2
FIG. 3 is a chromatographic purity HPLC chart of Compound c prepared in example 1
FIG. 4 is a chromatographic purity HPLC chart of Compound c prepared in example 2
FIG. 5 is an optical purity HPLC chart of Compound 1b prepared in comparative example 1
Detailed Description
The present invention is further illustrated below with reference to specific examples, but the scope of the present invention is not limited by the following examples.
The room temperature referred to in the present invention means 20.+ -. 5 ℃.
The optical purity in the examples was measured by HPLC and given as area percent.
Liquid phase conditions:
Chromatographic column: OJ-H4.6 x 250mm/5 μm
Mobile phase: n-hexane: ethanol: trifluoroacetic acid=90%: 10%:0.1%
Sample preparation: weighing 10mg of the sample, precisely weighing, placing into a 20ml volumetric flask, adding mobile phase, dissolving, diluting to scale, and shaking. 2 parts were prepared in parallel and the solution was stable for 8 hours after preparation.
Wavelength: 220nm;
Flow rate: 0.6ml/min;
Sample injection amount: 50 μl;
Column temperature: 25 ℃;
Run time: 30min
Example 1
Adding compound a (50.0 g) and N-N-octyl-D-glucosamine (292.0 g) into 2.5kg of acetone with 5% of water content, heating to 50 ℃ with stirring, dissolving, naturally cooling to room temperature after complete dissolution, cooling to-20 ℃ with heat preservation, stirring for 2h, filtering, drying at 50 ℃ under negative pressure to obtain 59.7 g of white solid, namely the lipoamine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (480 g), stirring and dissolving at 20-30 ℃ to obtain a clear solution, dropwise adding hydrochloric acid until the pH value of the system is 2-3 (120 g of concentrated hydrochloric acid is consumed), precipitating a large amount of solids, filtering, drying to obtain 21.3g (compound 1 a) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid, wherein the optical purity is 98.70% (the optical purity HPLC chart is shown in figure 1), and the yield is 42.6%.
20G of the mixture was charged into a high-pressure hydrogenation reactor, 128g of glacial acetic acid and 2.0g of 5% palladium on carbon were sequentially added, and then nitrogen was replaced three times and hydrogen was replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated and dried, then EA 20g is added to pulp for 1h, a large amount of white solid is generated, the white solid is filtered, EA 10g is used for leaching, and a filter cake is dried to obtain 16.7g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid with a yield of 88.45%.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 11.12g (compound c) of white solid (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid is obtained, and the yield is 90.10%. Chromatographic purity 99.61% (chromatographic purity HPLC profile see fig. 3), single impurity: 0.39%.
Example 2
Adding compound a (50.0 g) and L-lysine (29.09 g) into 200g of 95% ethanol, heating to 80 ℃ with stirring, naturally cooling to room temperature after dissolution, cooling to 20 ℃ and stirring for 2h, filtering, drying at 50 ℃ under negative pressure to obtain 56.8 g of white solid, namely L-lysine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (450 g), stirring and dissolving at 20-30 ℃ to obtain a solution, dropwise adding hydrochloric acid until the pH of the system is 2-3 (180 g of concentrated hydrochloric acid is consumed), precipitating a large amount of solid, filtering, and drying to obtain 20.2g of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), wherein the optical purity is 98.71% (the optical purity HPLC chart is shown in figure 2), and the yield is 40.4%.
20G of the mixture was charged into a high-pressure hydrogenation reactor, 128g of glacial acetic acid and 2.0g of 5% palladium on carbon were sequentially added, and then nitrogen was replaced three times and hydrogen was replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated and dried, then EA 20g is added to pulp for 1h, a large amount of white solid is generated, the white solid is filtered, EA 10g is used for leaching, and a filter cake is dried to obtain 16.4g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid with the yield of 86.86%.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 11.29g (compound c) of white solid (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid is obtained, and the yield is 91.46 percent. Chromatographic purity 99.52% (chromatographic purity HPLC profile see fig. 4), single impurity: 0.47%.
Example 3
Adding compound a (50.0 g) and L-arginine (27.73 g) into 100g of isopropanol with 6% of water content, heating to 50 ℃ with stirring, naturally cooling to room temperature after dissolution, keeping the temperature to 0 ℃ and stirring for 2h, filtering, drying at 50 ℃ under negative pressure to obtain 58.5 g of white solid, namely L-arginine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (480 g), stirring and dissolving at 20-30 ℃ to clear, dropwise adding hydrochloric acid until the pH of the system is 2-3 (consuming concentrated hydrochloric acid 120 g), precipitating a large amount of solids, filtering, and drying to obtain 20.8g of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), wherein the optical purity is 98.90%, and the yield is 41.6%.
20G of the mixture was charged into a high-pressure hydrogenation reactor, 128g of glacial acetic acid and 2.0g of 5% palladium on carbon were sequentially added, and then nitrogen was replaced three times and hydrogen was replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated and dried, then EA 20g is added to pulp for 1h, a large amount of white solid is generated, the white solid is filtered, EA 10g is used for leaching, and a filter cake is dried to obtain 16.6g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid with a yield of 88.29 percent.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 10.78g (compound c) of white solid, namely (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid, is obtained, and the yield is 87.37 percent. Chromatographic purity 99.75%, single impurity: 0.25%.
Example 4
Adding compound a (50.0 g) and S-alpha-phenethylamine (24.1 g) into 50g of sec-butyl alcohol with 10% of water content, heating to 100 ℃ with stirring, naturally cooling to room temperature after dissolution is completed, preserving heat and stirring for 2h at 50 ℃, filtering, drying at 50 ℃ under negative pressure to obtain 56.2 g of white solid, namely L-arginine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (480 g), stirring and dissolving at 20-30 ℃ until the pH of the system is 2-3 (consuming concentrated hydrochloric acid 120 g), precipitating a large amount of solids, filtering, and drying to obtain 20.1g of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), wherein the optical purity is 98.56%, and the yield is 40.2%.
20G of the mixture was charged into a high-pressure hydrogenation reactor, 128g of glacial acetic acid and 2.0g of 5% palladium on carbon were sequentially added, and then nitrogen was replaced three times and hydrogen was replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated and dried, then EA 20g is added to pulp for 1h, a large amount of white solid is generated, the white solid is filtered, EA 10g is used for leaching, and a filter cake is dried to obtain 17.2g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid with a yield of 91.48 percent.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 10.95g (compound c) of white solid, namely (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid, is obtained, and the yield is 88.73%. Chromatographic purity 99.58%, single impurity: 0.42%.
Example 5
Adding compound a (20.0 g) and N-N-octyl-D-glucosamine (23.3 g) into 200g of isopropanol with 3% of water content, heating to 60 ℃ to dissolve the materials completely, naturally cooling to room temperature, cooling to 10 ℃ to keep the temperature and stirring for 2 hours, filtering, drying at 50 ℃ under negative pressure to obtain 23.8 g of white solid, namely the meglumine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (192 g), stirring and dissolving at 20-30 ℃ to obtain a solution, dropwise adding hydrochloric acid until the pH of the system is 2-3 (48 g of concentrated hydrochloric acid is consumed), precipitating a large amount of solids, filtering and drying to obtain 8.50g (compound 1 a) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid with the optical purity of 98.27% and the yield of 42.5%.
8.0G of the mixture is added into a high-pressure hydrogenation kettle, 51.2g of glacial acetic acid and 0.8g of 5% palladium-carbon are sequentially added, and then nitrogen is replaced three times and hydrogen is replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated to dryness, then EA 8.0g is added to pulp for 1h, a large amount of white solid is generated, the mixture is filtered, EA 8.0g is used for leaching, and a filter cake is dried to obtain 6.6g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid, and the yield is 87.41%.
5.0G of the material is added into 30g of purified water and 10g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 6 hours, after the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and the white solid, namely 3.57g (compound c) of (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid is obtained, and the yield is 86.89 percent. Chromatographic purity 99.72%, single impurity: 0.28%.
Example 6
Adding compound a (50.0 g) and N-N-octyl-D-glucosamine (116.7 g) into 5.0kg of acetone with 1% of water content, heating to 55 ℃ with stirring to dissolve the mixture completely, naturally cooling to room temperature, cooling to 10 ℃ and preserving heat, stirring for 2 hours, filtering, drying at 50 ℃ under negative pressure to obtain 59.6 g of white solid, namely the meglumine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid (compound 1 a), adding the salt into purified water (480 g), stirring and dissolving at 20-30 ℃ to clear, dropwise adding hydrochloric acid until the pH of the system is 2-3 (118 g of concentrated hydrochloric acid is consumed), precipitating a large amount of solid, filtering and drying to obtain 21.0g (compound 1 a) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylcarbonyl butyric acid with optical purity of 98.39% and yield of 42.0%.
20G of the mixture was charged into a high-pressure hydrogenation reactor, 128g of glacial acetic acid and 2.0g of 5% palladium on carbon were sequentially added, and then nitrogen was replaced three times and hydrogen was replaced three times. Hydrogenation is carried out at the system temperature of 50+/-5 ℃ and the pressure of 1.2MPa to 1.4MPa until the raw materials are completely reacted. Palladium on carbon is filtered, the filtrate is concentrated and dried, then EA 20g is added to pulp for 1h, a large amount of white solid is generated, the white solid is filtered, EA 10g is used for leaching, and a filter cake is dried to obtain 16.5g (compound 1 b) of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid with a yield of 87.39%.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 10.98g (compound c) of white solid, namely (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid, is obtained, and the yield is 88.98 percent. Chromatographic purity 99.66%, single impurity: 0.34%.
Comparative example 1
Adding threo racemate (50.0 g) of a compound b and S-phenethylamine (26.0 g) into 250g of 95% ethanol, heating to 55-60 ℃ to dissolve the material under stirring, naturally cooling to room temperature after dissolving completely, cooling to 0-10 ℃ again, preserving heat and stirring for 24h, filtering to obtain 40.8g of a filter cake wet product, adding the filter cake wet product into 200g of 95% ethanol, heating to 55-60 ℃ to dissolve the material under stirring, naturally cooling to room temperature after dissolving completely, cooling to 0-10 ℃ again, preserving heat and stirring for 24h, filtering, drying at 60 ℃ under negative pressure to obtain 20.3 g of white solid, namely S-phenethylamine salt of (2S, 3R) -2-hydroxy-3-acetamido-4-phenylbutyric acid (compound 1 b), wherein the optical purity is 96.44% (the optical purity HPLC chart is shown in figure 5), and the yield is 26.87%.
15G of the material is added into 100g of purified water and 20g of concentrated hydrochloric acid, the mixture is heated to reflux under stirring, the reflux reaction is maintained for 8 hours, the reaction is completed, the mixture is concentrated to dryness, 2mol/L sodium hydroxide solution is slowly added to adjust the pH to 5-6, a large amount of white solid is separated out, the temperature is reduced to below 10 ℃ of the system, the mixture is centrifuged and dried, and 10.40g (compound c) of white solid, namely (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid, is obtained, and the yield is 83.50 percent.
It is to be understood that the foregoing detailed description and accompanying examples are merely exemplary and are not to be considered limiting the scope of the invention, which is defined solely by the appended claims and their equivalents. Various alterations and modifications to the disclosed embodiments will be readily apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present invention as defined by the appended claims.

Claims (12)

1. A preparation method of ubenimex intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (c), which is characterized by comprising the following steps:
Separating the compound a by a resolution reagent to obtain a compound 1a, then hydrogenating the compound 1a to obtain a compound 1b, and hydrolyzing the compound to obtain an intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (c); wherein the resolving agent is selected from N-N-octyl-D-glucosamine.
2. The preparation method according to claim 1, wherein the compound a is composed of a compound 1a and a compound 2 a:
3. The preparation method according to claim 1, wherein the molar ratio of the compound a to the resolving agent is 1: (0.5-7).
4. The preparation method according to claim 1, wherein the molar ratio of the compound a to the resolving agent is 1: (0.8-5).
5. The method of manufacturing according to claim 1, comprising the steps of:
1) Mixing the compound a with a resolution reagent in an aqueous solvent to form salt, and cooling to separate out salt crystals;
2) Dissolving the salt obtained in the step 1) in an aqueous solution, and adding a proper amount of acid to enable the compound 1a to be separated out in a free way;
3) Adding the compound 1a obtained in the step 2) into a solvent for hydrogenation to obtain a compound 1b;
4) And (3) adding acid to hydrolyze the compound 1b obtained in the step (3) to obtain an intermediate (2S, 3R) -2-hydroxy-3-amino-4-phenylbutyric acid (c).
6. The method of claim 5, wherein the aqueous solvent is selected from isopropanol, ethanol, acetone, and sec-butanol; the water content of the aqueous solvent is 0.5-15%.
7. The method according to claim 6, wherein the aqueous solvent has a water content of 1% to 10%.
8. The process according to claim 5, wherein the temperature range at which the compound a and the resolving agent are mixed in the aqueous solvent in step 1) is 50 to 100 ℃.
9. The method according to claim 5, wherein the temperature reduction range in step 1) is-20 to 50 ℃.
10. The process according to claim 5, wherein the weight ratio of the compound a to the aqueous solvent in the step 1) is 1 (0.5 to 120).
11. The process according to claim 10, wherein the weight ratio of the compound a to the aqueous solvent in step 1) is 1 (1-100).
12. The process of claim 5, wherein the acid in step 2) or 4) is a protic acid.
CN202211484290.2A 2022-11-24 2022-11-24 Preparation method of high-purity ubenimex intermediate Active CN115784918B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211484290.2A CN115784918B (en) 2022-11-24 2022-11-24 Preparation method of high-purity ubenimex intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211484290.2A CN115784918B (en) 2022-11-24 2022-11-24 Preparation method of high-purity ubenimex intermediate

Publications (2)

Publication Number Publication Date
CN115784918A CN115784918A (en) 2023-03-14
CN115784918B true CN115784918B (en) 2024-10-15

Family

ID=85441157

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211484290.2A Active CN115784918B (en) 2022-11-24 2022-11-24 Preparation method of high-purity ubenimex intermediate

Country Status (1)

Country Link
CN (1) CN115784918B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322711A (en) * 2001-05-10 2001-11-21 武汉大学 Prepn of optically active chloromycetin
CN101891647A (en) * 2010-03-15 2010-11-24 浙江普洛康裕制药有限公司 A kind of preparation method of ubenimex

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1182125A (en) * 1978-11-25 1985-02-05 Hamao Umezawa Process for producing threo-3-amino-2- hydroxybutanoyl-aminoacetic acids, as well as novel intermediates therefor and process for producing them
JPH064569B2 (en) * 1985-01-14 1994-01-19 日本化薬株式会社 Novel method for producing threo- (2RS) -3-amino-2-hydroxy-4-oxo-4-phenylbutyric acid derivative

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322711A (en) * 2001-05-10 2001-11-21 武汉大学 Prepn of optically active chloromycetin
CN101891647A (en) * 2010-03-15 2010-11-24 浙江普洛康裕制药有限公司 A kind of preparation method of ubenimex

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A facile synthesis of bestatin;Nishizawa, Rinzo等;《Journal of Antibiotics》;第36卷(第6期);第696-698页 *

Also Published As

Publication number Publication date
CN115784918A (en) 2023-03-14

Similar Documents

Publication Publication Date Title
CN111646922B (en) Synthetic method of 2- (4-bromo-2-cyano-6-fluorophenyl) acetic acid
CN102241555B (en) Method for preparing photoactived amino acid through resolution
CN113999142B (en) Preparation method of chiral N-Boc-trans-1, 2-cyclohexanediamine
CN113801029A (en) Preparation method of levalbuterol hydrochloride
CN115784918B (en) Preparation method of high-purity ubenimex intermediate
CN111606826A (en) A kind of preparation method of edoxaban intermediate
CN114181117B (en) Preparation method of peramivir intermediate
CN111170878B (en) Method for preparing D-type or L-type tert-leucine
HU229188B1 (en) Process for the preparation of n-[(s)-1-carboxybutyl]-(s)-alanine esters and their use for synthesizing perindopril
CN119110730A (en) Method for preparing ipraglimine and its salt
WO2008096373A2 (en) Process for synthesizing highly pure nateglinide polymorphs
EP1300392A1 (en) Process for producing optically active alpha-amino acid and optically active alpha-amino acid amide
AU2002330738B2 (en) Process for the preparation of (R)- or (S)-Aminocarnitine inner salt, the salts and derivatives thereof
CN109824539B (en) Novel method for synthesizing tigecycline from demethyl aureomycin
CN107827802B (en) Synthesis method of D-proline
CN110845368A (en) Method for synthesizing chiral N-substituted- α -amino acid compound by chemical resolution method
EP1142864A1 (en) Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
CN120271495B (en) A method for synthesizing (3R, 4R)-N-PG-4-amino-3-methylpiperidine
CN112521318A (en) Preparation method of amisulpride important intermediate
CN104592046A (en) Optically active valine compound and production method thereof
US6008403A (en) Method for producing optically active amino acid of derivative thereof having high optical purity
AU2002330738A1 (en) Process for the preparation of (R)- or (S)-Aminocarnitine inner salt, the salts and derivatives thereof
CN111233685B (en) Preparation method of racemic D/L-tert-leucine
DE112008000311T5 (en) A method of collecting an L-biphenylalanine compound salt and a method of collecting a biphenylalanine ester compound using the same
CN109251163B (en) Resolution method of indoline-2-formic acid compound and intermediate thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant